114804-76-1

Basic information

• Product Name: 2-Naphthalenecarboxylic acid, 6-(phenylmethoxy)-, methyl ester
• CAS NO: 114804-76-1
• Molecular Formula: C19H16O3
• Molecular Weight: 292.334
• Mol File: 114804-76-1.mol

Chemical Properties

• CAS DataBase Reference: 2-Naphthalenecarboxylic acid, 6-(phenylmethoxy)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Naphthalenecarboxylic acid, 6-(phenylmethoxy)-, methyl ester(114804-76-1)
• EPA Substance Registry System: 2-Naphthalenecarboxylic acid, 6-(phenylmethoxy)-, methyl ester(114804-76-1)

Safety Data

• Hazardous Substances Data: 114804-76-1(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 114804-77-2 1,2,3,4-tetrahydro-6-benzyloxy-2-naphthoic acid 
• 17295-11-3 methyl 6-hydroxynaphthalene-2-carboxylate 
• 100-44-7 benzyl chloride 
• 78-93-3 butanone 
• 16712-64-4 6-Hydroxy-2-naphthoic acid 
• 100-39-0 benzyl bromide 
• 66217-29-6 6-(benzyloxy)-2-cyanonaphthalene 
• 2234-45-9 6-benzyloxy-2-bromonaphthalene 
• 15231-91-1 6-bromo-naphthalen-2-ol 

Downstream Products

• 895520-75-9 3-(6-benzyloxynaphthalen-2-yl)pentan-3-ol 
• 114804-77-2 1,2,3,4-tetrahydro-6-benzyloxy-2-naphthoic acid 
• 1606979-39-8 C₃₆H₄₆O₃ 
• 536974-71-7 [6-(benzyloxy)naphthalen-2-yl]methanol 
• 905853-68-1 (6-benzyloxy-naphthalen-2-ylmethyl)-(4-fluoro-benzyl)-carbamic acid tert-butyl ester 
• 905853-67-0 (6-benzyloxy-naphthalen-2-ylmethyl)-(4-fluoro-benzyl)-amine 
• 131965-79-2 6-(benzyloxy)-2-naphthaldehyde 
• 17295-11-3 methyl 6-hydroxynaphthalene-2-carboxylate 

Relevant articles and documents

Multichromophoric cyclodextrins. 4. Light conversion by antenna effect

A water soluble β-cyclodextrin (CD-NA) bearing seven naphthoyl chromophores forms very stable 1:1 complexes with a merocyanine laser dye DCM-OH (4-(dicyanomethylene)-2-methyl-6-(p-(bis(hydroxyethyl)amino)-styryl)-4 H-pyran). The antenna effect, i.e. energ

Structure-activity relationships for vitamin D3-based aromatic a-ring analogues as hedgehog pathway inhibitors

A structure-activity relationship study for a series of vitamin D3-based (VD3) analogues that incorporate aromatic A-ring mimics with varying functionality has provided key insight into scaffold features that result in potent, selective Hedgehog (Hh) pathway inhibition. Three analogue subclasses containing (1) a single substitution at the ortho or para position of the aromatic A-ring, (2) a heteroaryl or biaryl moiety, or (3) multiple substituents on the aromatic A-ring were prepared and evaluated. Aromatic A-ring mimics incorporating either single or multiple hydrophilic moieties on a six-membered ring inhibited the Hh pathway in both Hh-dependent mouse embryonic fibroblasts and cultured cancer cells (IC50 values 0.74-10 μM). Preliminary studies were conducted to probe the cellular mechanisms through which VD3 and 5, the most active analogue, inhibit Hh signaling. These studies suggested that the anti-Hh activity of VD3 is primarily attributed to the vitamin D receptor, whereas 5 affects Hh inhibition through a separate mechanism.

VITAMIN D RECEPTOR MODULATORS

The present invention relates to novel, non-secosteroidal, phenyl-naphthalene compounds of Formula (I): wherein R, R1, RP, ZP, LP1, LP2 LNP, RP3, RN, and ZNP are defined herein, their prepa

NOVEL COMPOUNDS AND THEIR USE IN MEDICINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

The present invention relates to novel compounds of formula (I) and their pharmaceutically acceptable salts thereof, pharmaceutical compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds.

Optically active naphthalene compounds and liquid crystal materials and devices incorporating them

Optically active naphthalene compounds having the formula: STR1 in which X and Y are selected from combinations (a), (b) and (c): (a) X is C1-10 alkyl or alkoxy and Y is C4-16 optically active alkyl, (b) X is C1-10 alkyl o